Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 1
1979 1
1981 1
1982 1
1986 1
1988 2
1989 1
1990 1
1992 2
1993 1
1994 3
1995 2
1996 3
1997 2
1998 1
1999 2
2000 1
2001 3
2003 1
2004 4
2005 6
2006 2
2007 4
2008 6
2009 2
2010 2
2011 5
2012 8
2013 6
2014 9
2015 1
2016 4
2017 4
2019 1
2020 1
2021 9
2022 10
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators. Reif A, et al. N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145. N Engl J Med. 2023. PMID: 37792613 Clinical Trial.
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Stromal nicotinamide N-methyltransferase orchestrates the crosstalk between fibroblasts and tumour cells in oral squamous cell carcinoma: evidence from patient-derived assembled organoids.
Zhao H, Li R, Chen Y, Yang X, Shang Z. Zhao H, et al. Oncogene. 2023 Apr;42(15):1166-1180. doi: 10.1038/s41388-023-02642-5. Epub 2023 Feb 23. Oncogene. 2023. PMID: 36823377
Further investigations confirmed that the stromal NNMT-aggravated oncogenic activities were attenuated by treatment with inhibitors of either collagen synthesis (e.g. losartan, tranilast, and halofuginone) in fibroblasts, or the focal adhesion kinase (FAK) signal (i.e. def …
Further investigations confirmed that the stromal NNMT-aggravated oncogenic activities were attenuated by treatment with inhibitors of eithe …
Optimizing extended-release carbidopa/levodopa in Parkinson disease: Consensus on conversion from standard therapy.
Espay AJ, Pagan FL, Walter BL, Morgan JC, Elmer LW, Waters CH, Agarwal P, Dhall R, Ondo WG, Klos KJ, Silver DE. Espay AJ, et al. Neurol Clin Pract. 2017 Feb;7(1):86-93. doi: 10.1212/CPJ.0000000000000316. Neurol Clin Pract. 2017. PMID: 28243505 Free PMC article. Review.
Initial regimens may be based on doubling the patient's preconversion levodopa daily dosage and choosing a division of doses to address the patient's motor complications, e.g., wearing-off (warranting a relatively high ER CD/LD dose, possibly at a lower frequency than for …
Initial regimens may be based on doubling the patient's preconversion levodopa daily dosage and choosing a division of doses to address the …
Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
Smith EE, Shoamanesh A, Xu L, Heenan L, Saad F, Colorado P, Chen CH, Lemmens R, De Marchis GM, Caso V, Masjuan J, Hirano T, Milanov I, Campbell BCV, Mas JL, Connolly SJ, Mundl H, Hart RG; PACIFIC-Stroke Steering Committee and Investigators. Smith EE, et al. Stroke. 2024 Feb;55(2):392-402. doi: 10.1161/STROKEAHA.123.043198. Epub 2024 Jan 4. Stroke. 2024. PMID: 38174569 Clinical Trial.
Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.
Camilleri M, Subramanian T, Pagan F, Isaacson S, Gil R, Hauser RA, Feldman M, Goldstein M, Kumar R, Truong D, Chhabria N, Walter BL, Eskenazi J, Riesenberg R, Burdick D, Tse W, Molho E, Robottom B, Bhatia P, Kadimi S, Klos K, Shprecher D, Marquez-Mendoza O, Hidalgo G, Grill S, Li G, Mandell H, Hughes M, Stephenson S, Vandersluis J, Pfeffer M, Duker A, Shivkumar V, Kinney W, MacDougall J, Zasloff M, Barbut D. Camilleri M, et al. Ann Intern Med. 2022 Dec;175(12):1666-1674. doi: 10.7326/M22-1438. Epub 2022 Nov 8. Ann Intern Med. 2022. PMID: 36343348 Clinical Trial.
Impact of energy density on energy intake in children and adults: a systematic review and meta-analysis of randomized controlled trials.
Klos B, Cook J, Crepaz L, Weiland A, Zipfel S, Mack I. Klos B, et al. Eur J Nutr. 2023 Apr;62(3):1059-1076. doi: 10.1007/s00394-022-03054-z. Epub 2022 Dec 2. Eur J Nutr. 2023. PMID: 36460778 Free PMC article. Review.
METHODS: The systematic literature search of multiple databases according to PRISMA criteria considered RCTs investigating the objectively measured energy intake from meals with different ED (lower ED (median 1.1 kcal/g) versus higher ED (median 1.5 kcal/g)) under c …
METHODS: The systematic literature search of multiple databases according to PRISMA criteria considered RCTs investigating the objectively m …
Infection and musculoskeletal conditions: Reactive arthritis.
Rihl M, Klos A, Köhler L, Kuipers JG. Rihl M, et al. Best Pract Res Clin Rheumatol. 2006 Dec;20(6):1119-37. doi: 10.1016/j.berh.2006.08.008. Best Pract Res Clin Rheumatol. 2006. PMID: 17127200 Review.
Pathogenesis involves the modification of host cells by pathogen-associated molecular patterns (PAMPs, e.g. lipopolysaccharide), bacterial effector proteins, the adaptive immune system, and the genetic background. ...
Pathogenesis involves the modification of host cells by pathogen-associated molecular patterns (PAMPs, e.g. lipopolysaccharide), bact …
Binding mechanisms in dendrimer-surfactant complexes.
Kłos JS, Paturej J. Kłos JS, et al. Phys Rev E. 2022 Mar;105(3-1):034501. doi: 10.1103/PhysRevE.105.034501. Phys Rev E. 2022. PMID: 35428143
We recognize two crucial parameters that govern association of surfactants within dendrimers: surfactant hydrophobicity, epsilon^{*}, and dendrimer generation, G. We find that depending on the values of epsilon^{*} and G encapsulation of surfactants by dendrimers is …
We recognize two crucial parameters that govern association of surfactants within dendrimers: surfactant hydrophobicity, epsilon^{*}, and de …
The significance of heterophasic ion exchange in active biomonitoring of heavy metal pollution of surface waters.
Kłos A, Wierzba S, Świsłowski P, Cygan A, Gruss Ł, Wiatkowski M, Pulikowski K, Ziembik Z, Dołhańczuk-Śródka A, Rajfur M, Jerz D, Piechaczek-Wereszczyńska M, Rosik-Dulewska C, Wieczorek P. Kłos A, et al. Sci Rep. 2023 Oct 1;13(1):16500. doi: 10.1038/s41598-023-43454-7. Sci Rep. 2023. PMID: 37779153 Free PMC article.

High increments of nickel concentrations in the algae Palmaria palmata (mean: 0.0040 mg/g, with the initial concentration of c(0) < 0.0016 in the algae) were noted, with negligible increments in concentrations of this metal in mosses and lichens. In contrast, mosses and

…
High increments of nickel concentrations in the algae Palmaria palmata (mean: 0.0040 mg/g, with the initial concentration of c(0) &lt …
113 results